This biotech specializing in endocrine therapies reported a notable insider sale as it advances clinical-stage drug candidates.
This spine-focused medtech firm, known for its surgical innovations, reported a notable insider sale amid ongoing portfolio expansion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results